Suppr超能文献

用于非综合征性早发性严重肥胖的靶向下一代测序面板,以及在 MC4R 和 LEP 基因中鉴定新的可能致病性变异。

A Targeted Next Generation Sequencing Panel for Non-syndromic Early Onset Severe Obesity and Identification of Novel Likely -Pathogenic Variants in the MC4R and LEP Genes.

机构信息

Department of Growth and Pediatric Endocrinology, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, Maharashtra, 411 001, India.

Molecular Genetics, GenePath Diagnostics; I-SHARE Foundation, J.M. Road, Shivajinagar, Pune, India.

出版信息

Indian J Pediatr. 2020 Feb;87(2):105-110. doi: 10.1007/s12098-019-03129-6. Epub 2020 Jan 11.

Abstract

OBJECTIVES

To screen for variants in the MC4R and LEP genes in 46 patients with clinical suspicion of non-syndromic early onset severe obesity (NEOSO).

METHODS

Children with early onset obesity satisfying WHO criteria of obesity were studied. The MC4R and LEP genes were sequenced using a PCR amplicon based NGS on Illumina MiSeq next generation sequencer using an in-house developed protocol.

RESULTS

Of the 46 children tested, four were found to have novel pathogenic/likely-pathogenic variants (one in the MC4R gene and three in the LEP gene). In three out of the 4 families, the presence of the variants was confirmed using standard bidirectional capillary sequencing in the probands.

CONCLUSIONS

Four children with novel likely pathogenic variants in the MC4R and LEP genes are reported. Genetic analysis is crucial in children with early onset obesity and should be considered.

摘要

目的

在 46 名临床疑似非综合征性早发性重度肥胖(NEOSO)患者中筛查 MC4R 和 LEP 基因的变异。

方法

研究了符合肥胖症世卫组织标准的早发性肥胖儿童。使用基于 PCR 扩增子的 NGS 对 Illumina MiSeq 下一代测序仪上的 MC4R 和 LEP 基因进行测序,使用内部开发的方案。

结果

在 46 名受检儿童中,发现了四个新的致病性/可能致病性变异(一个在 MC4R 基因,三个在 LEP 基因)。在 4 个家庭中的 3 个中,通过对先证者进行标准的双向毛细管测序证实了变异的存在。

结论

报告了 4 名儿童在 MC4R 和 LEP 基因中存在新的可能致病性变异。遗传分析对于早发性肥胖儿童至关重要,应予以考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验